Business Description
CervoMed Inc
NAICS : 325414
SIC : 2834
ISIN : US15713L1098
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 66.7 | |||||
3-Year EPS without NRI Growth Rate | 66.8 | |||||
3-Year FCF Growth Rate | 47.1 | |||||
3-Year Book Growth Rate | -64.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | -60.97 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 38.51 | |||||
12-1 Month Momentum % | -28.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.73 | |||||
Quick Ratio | 14.73 | |||||
Cash Ratio | 14.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -88 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -29.15 | |||||
ROA % | -25.5 | |||||
ROIC % | -471.93 | |||||
3-Year ROIIC % | -80.25 | |||||
ROCE % | -29.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.04 | |||||
Price-to-Tangible-Book | 2.05 | |||||
EV-to-EBIT | -11.19 | |||||
EV-to-EBITDA | -11.19 | |||||
EV-to-FCF | -7.48 | |||||
Price-to-Net-Current-Asset-Value | 2.32 | |||||
Price-to-Net-Cash | 2.44 | |||||
Earnings Yield (Greenblatt) % | -8.94 | |||||
FCF Yield % | -7.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CervoMed Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.656 | ||
Beta | 0 | ||
Volatility % | 67.4 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 6.524 | ||
12-1 Month Momentum % | -28.11 | ||
52-Week Range (€) | 3.779999 - 8.924999 | ||
Shares Outstanding (Mil) | 5.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CervoMed Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CervoMed Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
CervoMed Inc Frequently Asked Questions
What is CervoMed Inc(FRA:DP8)'s stock price today?
When is next earnings date of CervoMed Inc(FRA:DP8)?
Does CervoMed Inc(FRA:DP8) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |